Gefitinib/Chemotherapy vs Chemotherapy in EGFR Mutation-Positive NSCLC Resistant to First-Line Gefitinib: IMPRESS T790M Subgroup Analysis
- Resource Type
- Journal
- Authors
- Soria, Jean-Charles; Kim, Sang-We; Wu, Yi-Long; Nakagawa, Kazuhiko; Yang, Jin-Ji; Ahn, Myung-Ju; Wang, Jie; Yang, James Chih-Hsin; Lu, You; Atagi, Shinji; Ponce, Santiago; Shi, Xiaojin; Taylor, Rosemary; Jiang, Haiyi; Thress, Kenneth; Mok, Tony
- Source
- JOURNAL OF THORACIC ONCOLOGY; SEP 2015, 10 9, pS207-pS208, 2p. Supplement: 2
- Subject
- Language
- English
- ISSN
- 15561380